Sonic Incytes Medical Corp. is a healthtech company based in Vancouver, Canada, founded in 2017. The company specializes in developing the VELACUR™ device, an AI-guided 3D S-WAVE ultrasound elastography tool designed for the assessment of fatty liver disease. VELACUR™ offers deeper measurements and larger tissue samples compared to traditional methods, making it suitable for a range of body types. The device is designed for use by trained medical professionals without requiring sonography experience, thus enhancing accessibility and affordability in liver health assessments. Sonic Incytes aims to make liver health a new vital sign, positioning itself as a leader in point-of-care ultrasound technology with a focus on improving patient outcomes in liver disease management.
Something looks off?On-site & Remote